PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-32.44%
Negative 5Y CAGR while EXP stands at 63.58%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-44.51%
Negative 3Y CAGR while EXP stands at 37.92%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
486.80%
5Y OCF/share CAGR above 1.5x EXP's 263.60%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
2310.96%
3Y OCF/share CAGR above 1.5x EXP's 207.81%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
354.02%
5Y net income/share CAGR 1.25-1.5x EXP's 287.15%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
-35.62%
Negative 3Y CAGR while EXP is 75.71%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
51.34%
5Y equity/share CAGR above 1.5x EXP's 31.26%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
46.80%
3Y equity/share CAGR above 1.5x EXP's 3.16%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
135.88%
Stable or rising mid-term dividends while EXP is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
55.15%
Our short-term dividend growth is positive while EXP cut theirs. John Neff views it as a comparative advantage in shareholder returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.